Treg in type 1 diabetes

Cell Biochemistry and Biophysics

Volumn 48, Issue 2-3, 2007, Pages 165-175

  Brusko, Todd ^a   Atkinson, Mark ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; CD4 +CD25+ T Cells; Diabetes mellitus, Type 1; Regulatory T cells

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; FOXP3 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOLOGY; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 34548299917     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-007-0018-5     Document Type: Article

References (104)

1. Atkinson, M. A., & Eisenbarth, G. S. (2001). Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet, 358, 221-229.
2. Bach, J. F., & Chatenoud, L. (2001). Tolerance to islet autoantigens in type 1 diabetes. Annual Review of Immunology, 19, 131-161.
3. Beard, M. E., Willis, J. A., Scott, R. S., & Nesbit, J. W. (2002). Is type 1 diabetes transmissible by bone marrow allograft? Diabetes Care, 25, 799-800.
4. Serreze, D. V., & Leiter, E. H. (2003). Tracking autoimmune T cells in diabetes. Journal of Clinical Investigation, 112, 826-828.
5. + T cells. Advances in Immunology, 81, 331-371.
6. + T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes, 53, 1987-1994.
7. + regulatory T cells. Seminars in Immunology, 16, 89-98.
8. Atkinson, M. A., & Leiter, E. H. (1999). The NOD mouse model of type 1 diabetes: As good as it gets? Nature Medicine, 5, 601-604.
9. Rapoport, M. J., Lazarus, A. H., Jaramillo, A., Speck, E., & Delovitch, T. L. (1993). Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. Journal of Experimental Medicine, 177, 1221-1226.
10. +-like thymocytes in the NOD mouse. European Journal of Immunology, 26, 2989-2998.
11. King, C., Ilic, A., Koelsch, K., & Sarvetnick, N. (2004). Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell, 117, 265-277.
12. Lederman, M. M., Ellner, J. J., & Rodman, H. M. (1981). Defective suppressor cell generation in juvenile onset diabetes. Journal of Immunology, 127, 2051-2055.
13. Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996). Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. Journal of Experimental Medicine, 184, 387-396.
14. + immunoregulatory T cells that control autoimmune diabetes. Immunity, 12, 431-440.
15. + T cell levels in NOD mice. Proceedings of the National Academic Science USA, 99, 12287-12292.
16. Liu, J., & Beller, D. (2002). Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-kappa B expression and binding to the IL-12 p40 promoter. Journal of Immunology, 169, 581-586.
17. Serreze, D. V., Gaskins, H. R., & Leiter, E. H. (1993). Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. Journal of Immunology, 150, 2534-2543.
18. Alleva, D. G., Pavlovich, R. P., Grant, C., Kaser, S. B., & Beller, D. I. (2000). Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: Elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes, 49, 1106-1115.
19. Dahlen, E., Hedlund, G., & Dawe, K. (2000). Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. Journal of Immunology, 164, 2444-2456.
20. Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., Porcelli, S., & Maclaren, N. (2002). Multiple immuno-regulatory defects in type-1 diabetes. Journal of Clinical Investigation, 109, 131-140.
21. Weaver Jr., D. J., Poligone, B., Bui, T., Abdel-Motal, U. M., Baldwin Jr., A. S., & Tisch, R. (2001). Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase. Journal of Immunology, 167, 1461-1468.
22. Yan, G., Shi, L., Penfornis, A., & Faustman, D. L. (2003). Impaired processing and presentation by MHC class II proteins in human diabetic cells. Journal of Immunology, 170, 620-627.
23. Atkinson, M. A., Kaufman, D. L., Campbell, L., Gibbs, K. A., Shah, S. C., Bu, D. F., Erlander, M. G., Tobin, A. J., & Maclaren, N. K. (1992). Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet, 339, 458-459.
24. Roep, B. O., Kallan, A. A., Duinkerken, G., Arden, S. D., Hutton, J. C., Bruining, G. J., & de Vries, R. R. (1995). T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM. Diabetes, 44, 278-283.
25. Atkinson, M. A., Bowman, M. A., Campbell, L., Darrow, B. L., Kaufman, D. L., & Maclaren, N. K. (1994). Cellular immunity to a determinant common to glutamate decarboxylase and cox-sackie virus in insulin-dependent diabetes. Journal of Clinical Investigation, 94, 2125-2129.
26. Brooks-Worrell, B. M., Starkebaum, G. A., Greenbaum, C., & Palmer, J. P. (1996). Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. Journal of Immunology, 157, 5668-5674.
27. Peakman, M., Stevens, E. J., Lohmann, T., Narendran, P., Dromey, J., Alexander, A., Tomlinson, A. J., Trucco, M., Gorga, J. C., & Chicz, R. M. (1999). Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. Journal of Clinical Investigation, 104, 1449-1457.
28. Alleva, D. G., Crowe, P. D., Jin, L., Kwok, W. W., Ling, N., Gottschalk, M., Conlon, P. J., Gottlieb, P. A., Putnam, A. L., & Gaur, A. (2001). A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. Journal of Clinical Investigation, 107, 173-180.
29. Viglietta, V., Kent, S. C., Orban, T., & Hafler, D. A. (2002). GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. Journal of Clinical Investigation, 109, 895-903.
30. Roep, B. O. (2003). The role of T-cells in the pathogenesis of type 1 diabetes: From cause to cure. Diabetologia, 46, 305-321.
31. Arif, S., Tree, T. I., Astill, T. P., Tremble, J. M., Bishop, A. J., Dayan, C. M., Roep, B. O., & Peakman, M. (2004). Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. Journal of Clinical Investigation, 113, 451-463.
32. Tree, T. I., Duinkerken, G., Willemen, S., de Vries, R. R., & Roep, B. O. (2004). HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65. Diabetes, 53, 1692-1699.
33. Chatenoud, L., Salomon, B., & Bluestone, J. A. (2001). Suppressor T cells - they're back and critical for regulation of autoimmunity! Immunological Reviews, 182, 149-163.
34. von Boehmer, H. (2005). Mechanisms of suppression by suppressor T cells. Nature Immunology, 6, 338-344.
35. + regulatory T cells in immunological tolerance to self and non-self. Nature Immunology, 6, 345-352.
36. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology, 22, 531-562.
37. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. International Immunology, 10, 1969-1980.
38. + immunoregulatory T cells is antigen nonspecific. Journal of Immunology, 164, 183-190.
39. Zola, H., Mantzioris, B. X., Webster, J., & Kette, F. E. (1989). Circulating human T and B lymphocytes express the p55 interleukin-2 receptor molecule (TAC, CD25). Immunology and Cell Biology, 67, 233-237.
40. Bluestone, J. A. (1997). Is CTLA-4 a master switch for peripheral T cell tolerance? Journal of Immunology, 158, 1989-1993.
41. +) immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity, 16, 311-323.
42. +) regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunology, 3, 135-142.
43. +T cells controlling distinct organ-specific autoimmune diseases. Proceedings of the National Academic Science USA, 100, 15806-15811.
44. + T-regulatory cell subset has optimal suppressive and proliferative potential. American Journal of Transplantation, 4, 65-78.
45. +CD25 high regulatory cells in human peripheral blood. Journal of Immunology, 167, 1245-1253.
46. +) thymocytes and peripheral T cells have immune suppressive activity in vitro. European Journal of Immunology, 31, 1247-1254.
47. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. Journal of Experimental Medicine, 188, 287-296.
48. +) T cells: Evidence from a lymphopenic T cell model. Immunity, 17, 425-436.
49. + T cell receptors. Immunity, 21, 267-277.
50. Suzuki, H., Kundig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J., Ohashi, P. S., & Griesser, H. (1995). Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science, 268, 1472-1476.
51. Malek, T. R., Porter, B. O., Codias, E. K., Scibelli, P., & Yu, A. (2000). Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. Journal of Immunology, 164, 2905-2914.
52. +) T cells: Evidence for two distinct regulatory mechanisms. European Journal of Immunology, 31, 1637-1645.
53. Kagami, S., Nakajima, H., Suto, A., Hirose, K., Suzuki, K., Morita, S., Kato, I., Saito, Y., Kitamura, T., & Iwamoto, I. (2001). Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood, 97, 2358-2365.
54. Takeda, I., Ine, S., Killeen, N., Ndhlovu, L. C., Murata, K., Satomi, S., Sugamura, K., & Ishii, N. (2004). Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. Journal of Immunology, 172, 3580-3589.
55. Kumanogoh, A., Wang, X., Lee, I., Watanabe, C., Kamanaka, M., Shi, W., Yoshida, K., Sato, T., Habu, S., Itoh, M., Sakaguchi, N., Sakaguchi, S., & Kikutani, H. (2001). Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development. Journal of Immunology, 166, 353-360.
56. +) regulatory T cell activity: It takes (IL2) two to tango. European Journal of Immunology, 35, 1336-1341.
57. +) T regulatory cell development during the neonatal period. Journal of Experimental Medicine, 201, 769-777.
58. +) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. Journal of Experimental Medicine, 201, 723-735.
59. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. Journal of Experimental Medicine, 198, 1875-1886.
60. + cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. Journal of Immunology, 171, 2270-2278.
61. + regulatory T cells in the absence of STAT1: Increased susceptibility to autoimmune disease. Journal of Experimental Medicine, 199, 25-34.
62. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., & Demengeot, J. (2003). Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. Journal of Experimental Medicine, 197, 403-411.
63. + regulatory cell activation and function by dendritic cells. International Immunology, 16, 1769-1780.
64. + regulatory T cells? European Journal of Immunology, 35, 1193-1200.
65. Fontenot, J. D., & Rudensky, A. Y. (2004). Molecular aspects of regulatory T cell development. Seminars in Immunology, 16, 73-80.
66. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., Bricarelli, F. D., Byrne, G., McEuen, M., Proll, S., Appleby, M., & Brunlow, M. E. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genetics, 27, 18-20.
67. Wildin, R. S., Smyk-Pearson, S., & Filipovich, A. H. (2002). Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. Journal of Medical Genetics, 39, 537-545.
68. Smyk-Pearson, S. K., Bakke, A. C., Held, P. K., & Wildin, R. S. (2003). Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes. Clinical and Experimental Immunology, 133, 193-199.
69. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 75, 253-261.
70. Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995). Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity, 3, 521-530.
71. Suzuki, H., Zhou, Y. W., Kato, M., Mak, T. W., & Nakashima, I. (1999). Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. Journal of Experimental Medicine, 190, 1561-1572.
72. Leveen, P., Larsson, J., Ehinger, M., Cilio, C. M., Sundler, M., Sjostrand, L. J., Holmdahl, R., & Karlsson, S. (2002). Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood, 100, 560-568.
73. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 270, 985-988.
74. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics, 27, 20-21.
75. Khattri, R., Kasprowicz, D., Cox, T., Mortrud, M., Appleby, M. W., Brunkow, M. E., Ziegler, S. F., & Ramsdell, F. (2001). The amount of scurfin protein determines peripheral T cell number and responsiveness. Journal of Immunology, 167, 6312-6320.
76. + regulatory T cells. Nature Immunology, 4, 330-336.
77. Hori, S., Nomura, T., & Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-1061.
78. Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F., & Ziegler, S. F. (2001). Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. Journal of Biological Chemistry, 276, 37672-37679.
79. Lehmann, O. J., Sowden, J. C., Carlsson, P., Jordan, T., & Bhattacharya, S. S. (2003). Fox's in development and disease. Trends Genetics, 19, 339-344.
80. + regulatory T cell subsets. Journal of Leukocyte Biology, 74, 471-478.
81. +) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. Journal of Experimental Medicine, 194, 629-644.
82. +) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. Journal of Experimental Medicine, 196, 237-246.
83. +. Journal of Clinical Investigation, 112, 1437-1443.
84. + T cells. Journal of Immunology, 173, 6526-6531.
85. +) regulatory T cells. Journal of Experimental Medicine, 201, 737-746.
86. + regulatory T cells. Journal of Experimental Medicine, 201, 1061-1067.
87. + T regulatory cells in humans. Human Immunology, 66, 13-20.
88. Jaeckel, E., von Boehmer, H., & Manns, M. P. (2005). Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes, 54, 306-310.
89. Grewal, I. S., Grewal, K. D., Wong, F. S., Wang, H., Picarella, D. E., Janeway Jr., C. A. , & Flavell, R. A. (2002). Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism. Journal of Autoimmunology, 19, 9-22.
90. + regulatory T cells during autoimmune diabetes. Journal of Experimental Medicine, 201, 1333-1346.
91. You, S., Belghith, M., Cobbold, S., Alyanakian, M. A., Gouarin, C., Barriot, S., Garcia, C., Waldmann, H., Bach, J. F., & Chatenoud, L. (2005). Autoimmune diabetes onset results from qualitative rather than quantitative age dependent changes in pathogenic T-cells. Diabetes, 54, 1415-1422.
92. + regulatory T cells in patients with multiple sclerosis. Journal of Experimental Medicine, 199, 971-979.
93. + regulatory T cells in autoimmune polyglandular syndrome Type II. Journal of Experimental Medicine, 199, 1285-1291.
94. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scandinavian Journal of Immunology, 59, 198-202.
95. +) T-cells from patients with type 1 diabetes. Diabetes, 54, 92-99.
96. +CD25 high regulatory T cells in human autoimmune diabetes. Journal of Autoimmunology, 24, 55-62.
97. + T-cells in type 1 diabetes. Diabetes, 54, 1407-1414.
98. Zavattari, P., Deidda, E., Pitzalis, M., Zoa, B., Moi, L., Lampis, R., Contu, D., Motzo, C., Frogia, P., Angius, E., Maioli, M., Todd, J. A., & Cucca, F. (2004). No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population. Diabetes, 53, 1911-1914.
99. Vella, A., Cooper, J. D., Lowe, C. E., Walker, N., Nutland, S., Widmer, B., Jones, R., Ring, S. M., McArdle, W., Pembrey, M. E., Strachan, D. P., Dunger, D. B., Twells, R. C., Clayton, D. G., & Todd, J. A. (2005). Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. American Journal of Human Genetics, 76, 773-779.
100. +) T cells. Clinical Immunology, 115, 10-18.
101. + regulatory T cells suppress effector T cell proliferation. Clinical Immunology, 115, 3-9.
102. + Regulatory T-Cells in Type 1 Diabetes. Diabetes, 56(3), 604-612.
103. + T reg cells. Journal ofExperimental Medicine, 203(7), 1701-1711.
104. + regulatory T cells of both healthy subjects and type 1 diabetic patients. Journal of Immunology, 177(12), 8338-8347.